BOULDER, Colo., Dec. 20, 2025 (GLOBE NEWSWIRE) -- As the gaming world braces for the next generation of console gaming, EasySMX, the leading manufacturer of gaming peripherals, today officially unveils the S10 Lite, a controller designed to redefine the entry-level experience for the New Nintendo Switch 2. Positioned as the definitive "Best Switch 2 Controller at $40," the S10 Lite combines "light entry" accessibility, striking aesthetics, and an intuitive "pick-up-and-play" design. It is engineered specifi ...

Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...

Core Insights - Palantir Technologies has seen a remarkable increase of 2,600% over the last three years, primarily due to its Artificial Intelligence Platform (AIP), which has established it as a significant government contractor with a growing commercial client base [1] - BigBear.ai, a smaller government contractor with a market capitalization of $2.5 billion, is also leveraging AI and cloud-based data analytics to provide solutions for the federal government, raising questions about its potential to replicate Palantir's success by 2026 [2] Company Overview - BigBear.ai specializes in creating customized AI-driven products aimed at supporting U.S. national security, integrating with clients' infrastructure to facilitate real-time decision-making [4] - The company's ConductorOS platform enables rapid deployment of AI models and connects to various sensors and unmanned vehicles, designed to work with multiple cloud services for effective data processing [5] - BigBear.ai also offers veriScan, an AI-based facial authentication platform utilized at airports and other entry points [5] Financial Performance - In 2025, BigBear.ai's stock has outperformed the market, increasing by 30%, although it has not matched Palantir's nearly 150% rise this year [6] - The company reported a revenue of $33.1 million in Q3, a decline of 20% year-over-year, attributed to reduced U.S. Army program volumes; however, it achieved a profit of $2.5 million compared to a net loss of $15.1 million in Q3 2024 [6][7] - BigBear.ai has a backlog of $376 million and projects full-year revenue between $125 million and $140 million [8]

Core Viewpoint - Aris Mining (ARMN) is recognized for its growth and valuation as a junior gold miner, particularly in comparison to Aura Minerals (AUGO) [1] Company Analysis - Aris Mining has shown impressive growth metrics that attract attention in the investment community [1] - The analysis emphasizes the importance of financial statements in understanding the company's potential and valuation [1] Investment Perspective - The author has established a beneficial long position in ARMN and AUGO, indicating confidence in their future performance [2] - The analysis aims to provide a fundamental view and streamlined research similar to institutional standards, focusing on long-term potential [1]

Core Insights - SPDR Portfolio S&P 500 ETF (SPYM) and Vanguard S&P 500 ETF (VOO) both track the S&P 500 Index, with VOO having a significant advantage in assets under management at $1.5 trillion compared to SPYM's $101.2 billion [2][8] - Both ETFs provide low-cost access to the U.S. large-cap market, with similar performance metrics and sector exposure [3][8] Cost & Size Comparison - SPYM has an expense ratio of 0.02%, while VOO's is slightly higher at 0.03% [4][5] - Both funds have a 1-year return of 12.8% and a dividend yield of 1.1% [4][5] - SPYM has a longer track record since its inception on November 8, 2005, compared to VOO, which started in 2010 [9] Performance & Holdings - Over a 5-year period, a $1,000 investment in both SPYM and VOO would grow to $1,871 [6] - VOO holds 505 stocks with 37% in technology, while SPYM holds 504 stocks with 36% in technology, indicating nearly identical sector weights [6][7] - The largest holdings for both ETFs include Nvidia, Microsoft, and Apple, closely mirroring the S&P 500 Index [6][7] Investor Considerations - Both ETFs are efficient for tracking the S&P 500, but investors should weigh the differences in AUM, expense ratios, and historical performance when choosing between them [9]

Core Insights - Netflix has experienced a significant share price increase of 696% over the past decade, with a current market capitalization of $431 billion as of December 16 [1] - The company is set to release its Q4 financial results on January 20, 2025, which will include an earnings call for shareholders [3][8] - Netflix has a track record of exceeding Wall Street earnings estimates, having reported higher earnings per share than consensus views in nine of the last eleven quarters [4] Acquisition Insights - Investors are particularly interested in management's commentary regarding the proposed acquisition of Warner Bros. Discovery's film and TV studios, as well as the HBO Max streaming platform, which could significantly impact the media and entertainment industry [5][8] Investment Considerations - Current analysts from The Motley Fool Stock Advisor have identified ten stocks they believe are better investment opportunities than Netflix at this time [6][8]

Lowering Cash-Secured Put Breakeven Price Points Means Greater Protection to the Downside with Lower Premium Returns click ↑ 4 FeaturedWhen executing our cash-secured put trades in bear, volatile or uncertain market conditions, it is reasonable to structure our trades with lower breakeven price points. This will come at the expense of lower initial time-value returns. It is imperative that we identify our initial time-value return goal range prior to establishing such trades.  What is the minimum acceptabl ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bitdeer Technologies Group due to alleged violations of federal securities laws, particularly concerning misleading statements about the company's SEALMINER A4 project and its delayed chip development [4][6]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses in Bitdeer to contact them to discuss legal options [1]. - A federal securities class action has been filed against Bitdeer, with a deadline of February 2, 2026, for investors to seek the role of lead plaintiff [4]. - The complaint alleges that Bitdeer and its executives made false statements regarding the readiness and efficiency of the SEAL04 chip [6]. Group 2: Financial Performance and Stock Impact - Bitdeer reported a third-quarter earnings per share of -$1.28, missing the consensus estimate of -$0.22, which led to a stock price drop of $2.63 per share (14.9%) to close at $15.02 on November 11, 2025 [7]. - Following a fire incident at its construction facility, Bitdeer's stock fell another $2.83 per share (20.3%) to close at $11.11 on November 13, 2025 [8]. Group 3: Company Background and Recovery Efforts - Faruqi & Faruqi has recovered hundreds of millions of dollars for investors since its founding in 1995, indicating a strong track record in securities law [5]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Bitdeer's conduct [10].

Core Insights - The article compares two ETFs: State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF (SPTM) and Vanguard Value ETF (VTV), highlighting their differing investment strategies and performance metrics [4][5]. Group 1: ETF Characteristics - SPTM offers broader exposure with 1,510 U.S. stocks across all market capitalizations, focusing heavily on technology (34%), financial services (13%), and consumer cyclicals (11%) [1]. - VTV targets large-cap value stocks, with significant allocations in financial services (25%), healthcare (15%), and industrials (13%), holding 331 positions [2]. - SPTM has a growth-oriented tilt, resulting in higher recent returns but also larger drawdowns compared to VTV, which is more defensive and income-focused [5][6]. Group 2: Performance Metrics - Since 2004, SPTM has delivered an annual total return growth of 10.2%, while VTV has achieved 9.3%. Over the last decade, SPTM's growth was 14.5% compared to VTV's 11.8% [6]. - Both ETFs slightly lagged behind the S&P 500, which rose 14.7% annually over the same period [6]. - VTV offers a higher dividend yield of 2.1%, one percentage point more than SPTM, appealing to income-focused investors [3][5]. Group 3: Investment Considerations - SPTM includes 1,000 additional stocks compared to the S&P 500, providing better market breadth, while its allocation to the "Magnificent Seven" is lower at 34% compared to 38% for the S&P 500 [7]. - VTV avoids many high-profile tech stocks, focusing instead on steady dividend-paying stocks, which may be appealing in a volatile market [8]. - The choice between SPTM and VTV ultimately depends on individual investor preferences, with VTV being favored for its income potential and lower risk profile [9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Skye Biosciences, Inc. due to allegations of violations of federal securities laws related to misleading statements about the effectiveness of its drug nimacimab [4][6]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses in Skye between November 4, 2024, and October 3, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Skye, with a deadline of January 16, 2026, for investors to seek the role of lead plaintiff [4]. Group 2: Allegations Against Skye - The complaint alleges that Skye and its executives made false and misleading statements regarding nimacimab, claiming it was more effective than it actually is [6]. - Specific allegations include that nimacimab's clinical, regulatory, and commercial prospects were overstated, leading to materially false public statements [6]. Group 3: Stock Price Impact - Following the announcement on October 6, 2025, that nimacimab did not achieve its primary endpoint in a clinical study, Skye's stock price fell by $2.85 per share, or 60%, closing at $1.90 per share [7].